Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab
Background The dynamic change in C-reactive protein (CRP) levels, CRP kinetics, is a prognostic factor for metastatic renal cell carcinoma (mRCC) in the tyrosine kinase inhibitor era. We investigated the impact of early CRP kinetics on the efficacy of nivolumab in patients with mRCC.Methods We perfo...
Saved in:
Main Authors: | Toshiki Kijima, Shohei Fukuda, Kazutaka Saito, Yosuke Yasuda, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Yukio Kageyama, Yasuhisa Fujii |
---|---|
Format: | article |
Language: | EN |
Published: |
BMJ Publishing Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/f825a204d6ee4a078c4f34cf42d92aee |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab
Published: (2021) -
Comparison of anterior chamber flare among different glaucoma surgeries
by: Tanito M, et al.
Published: (2019) -
Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
by: Alexander N Shoushtari, et al.
Published: (2021) -
Complete regression of metastatic malignant melanoma endoscopically after nivolumab administration
by: Dae Gon Ryu, et al.
Published: (2021) -
Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma
by: Koji Nakajima, et al.
Published: (2021)